Tag: Adhd medications

An estimated 70-80% of children and adults with ADHD respond well to stimulant medications like Adderall, but what if you're not among them, or the side effects are too severe? Is there anything better than Adderall for ADHD? For many, the answer lies in exploring a range of alternative medications and non-pharmacological therapies tailored to their unique needs and responses.

According to the American Society of Health-System Pharmacists (ASHP), there were 271 active drug shortages at the end of 2024, continuing a prolonged crisis. Affecting everything from critical cancer treatments to common antibiotics, the situation prompts a crucial question for patients and providers alike: **what drugs are in shortage right now in the USA**?

Over 80% of children with ADHD who are treated with stimulants experience significant symptom improvement, highlighting their effectiveness. Given these powerful effects, many people, especially parents, wonder: **are any ADHD medications safe**? The consensus among experts is that these medications are safe and effective when prescribed and carefully monitored by a healthcare professional.

Adderall, a central nervous system stimulant, is comprised of a mixture of amphetamine and dextroamphetamine salts. When seeking to determine what is the closest drug to Adderall, the best options are those that share a similar amphetamine-based mechanism, though non-stimulant alternatives are also available.

With approximately 9.4% of U.S. children aged 2-17 ever diagnosed with ADHD, understanding treatment timelines is crucial. For those considering the non-stimulant Kapvay, a common question is: how long does it take for Kapvay to work?

According to expert consensus and clinical studies, there is a general understanding of the approximate dose equivalence between Ritalin and Adderall. This is an important distinction to understand when considering what is 10 mg of Ritalin equal to in Adderall, as the medications have different active ingredients and mechanisms of action.

As of late 2024, the U.S. Food and Drug Administration (FDA) approved Onyda XR, the first liquid non-stimulant ADHD medication for children and adolescents aged six years and older. This milestone is part of an expanding range of options for what is the new drug for ADHD, offering alternatives to traditional stimulant treatments and diverse formulations to fit individual needs.

At the beginning of 2024, the American Society of Health-System Pharmacists (ASHP) reported a record 323 active drug shortages, the highest number since tracking began in 2001. This persistent issue affects a wide range of critical medications, leaving many patients and healthcare providers asking: what drug is currently in shortage? The answer involves a complex interplay of manufacturing challenges, increased demand, and regulatory hurdles impacting key drug classes from sterile injectables to ADHD stimulants.